Novel discriminative stimulus effects of TPA023B, subtype-selective γ-aminobutyric-acidA/benzodiazepine modulator: Comparisons with zolpidem, lorazepam, and TPA023
Keywords: لورازپام; GABA; Subtype selectivity; Anxiolytic; Drug discrimination; Abuse liability; Benzodiazepine; Lorazepam; Zolpidem; TPA023; TPA023B; Training; Rat;